SARS-CoV-2 Virus Reduction
- Authors
- Varun Dwivedi, Jun-Gyu Park, Stephen Grenon, Nicholas Medendorp, Cory Hallam, Jordi B. Torrelles,
- Facility
- Texas Biomedical Research Institute - San Antonio, TX
- Download
- Full Report
Objective
To evaluate the efficacy and the dose response of NuvaWave Instant UV handheld device in reducing the SARS-CoV-2 virus on surfaces.
Methodology
SARS-CoV-2 was dried on a chambered glass slides and introduced in a NuvaWave robotic testing unit. The programed robotic unit facilitated the exposure of pre-determined UVC radiation dose to the virus for 1, 2, 4 and 8 seconds. Post-UVC exposure, virus was recovered and titered by plaque assay in Vero E6 cells.
Summary of Results
The NuvaWave handheld device deactivated 99.88% of SARS-CoV-2 after one second of exposure.
